32 studies found for:    Proellex
Show Display Options
Rank Status Study
1 Terminated
Has Results
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex;   Drug: Placebo
2 Completed Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: 12.5 mg Proellex;   Drug: 25 mg Proellex;   Drug: Placebo
3 Completed Proellex Pharmacokinetics Bridging Study
Condition: Healthy
Interventions: Drug: 25 mg Proellex;   Drug: 50 mg Proellex
4 Terminated
Has Results
Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg
5 Completed
Has Results
Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults
Condition: Impaired Liver Function
Intervention: Drug: Proellex
6 Terminated
Has Results
Study to Evaluate Menses Induction in Women Administered Proellex
Condition: Amenorrhea
Interventions: Drug: Placebo;   Drug: Proellex
7 Terminated
Has Results
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg;   Drug: Lupron Depot
8 Completed A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Condition: Uterine Leiomyomata
Interventions: Drug: Progenta;   Drug: Lucron Depot;   Drug: Placebo
9 Terminated
Has Results
Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
Conditions: Uterine Fibroids;   Anemia
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg;   Drug: Placebo
10 Terminated
Has Results
Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
Condition: Renal Impairment
Intervention: Drug: 50 mg Proellex
11 Completed Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200
Condition: Uterine Fibroids
Interventions: Drug: Proellex 12 mg;   Drug: Proellex 24 mg
12 Completed
Has Results
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
Condition: Uterine Fibroids
Interventions: Drug: Proellex®;   Drug: Placebo
13 Terminated
Has Results
Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex;   Other: placebo
14 Completed Proellex® Pharmacokinetic Bridging Study II
Condition: Healthy
Intervention: Drug: Proellex 25 mg
15 Completed Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females
Conditions: ABSORPTION;   METABOLISM;   EXCRETION
Intervention: Drug: Proellex
16 Withdrawn Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
Condition: Uterine Fibroids
Intervention: Drug: Proellex
17 Completed
Has Results
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
Condition: Uterine Fibroids
Intervention: Drug: Proellex
18 Terminated
Has Results
Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
Condition: Endometriosis
Interventions: Drug: Proellex 25 mg;   Drug: Placebo;   Drug: Proellex 50 mg
19 Completed Comparison of Two Formulations of Proellex for Vaginal Administration
Condition: Comparison of 2 Different Formulations of 12 mg Proellex Vaginal Capsules
Interventions: Drug: Proellex Formulation A;   Drug: Proellex Formulation B
20 Terminated
Has Results
An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
Condition: Uterine Fibroids
Intervention: Drug: 25 mg Proellex

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years